Literature DB >> 23018637

TRAIL, a new weapon against neointimal hyperplasia.

Paola Secchiero, Giorgio Zauli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23018637     DOI： 10.1159/000342983

Source DB:  PubMed          Journal:  Cardiology        ISSN： 0008-6312            Impact factor:   1.869


× No keyword cloud information.
  2 in total

Review 1.  Clinical perspectives of TRAIL: insights into central nervous system disorders.

Authors:  Veronica Tisato; Arianna Gonelli; Rebecca Voltan; Paola Secchiero; Giorgio Zauli
Journal:  Cell Mol Life Sci       Date:  2016-02-24       Impact factor: 9.261

2.  The effectiveness of serum S100B, TRAIL, and adropin levels in predicting clinical outcome, final infarct core, and stroke subtypes of acute ischemic stroke patients.

Authors:  Ozge Altintas Kadirhan; Okkes Taha Kucukdagli; Bedia Gulen
Journal:  Biomedica       Date:  2022-05-01       Impact factor: 1.173
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.